Format

Send to

Choose Destination
Nat Biotechnol. 2007 May;25(5):513-21.

Proposition 71 and CIRM--assessing the return on investment.

Author information

1
Department of Surgery, Institute of Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, 257 Campus Drive West, Stanford, California 94305, USA. longaker@stanford.edu

Abstract

Given that Californian voters authorized state coffers to sell $3 billion in bonds to fund the California Institute for Regenerative Medicine (CIRM) with the expectation of health and financial benefits, what benchmarks should be used to measure the initiative's success?

PMID:
17483831
DOI:
10.1038/nbt0507-513
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center